We employed bioinformatics analysis to obtain the critical pathways and genes to identify molecular markers relating to the outcome of immunotherapy in NSCLC-PDT, and found HIF-1α to be a promising key gene closely correlating with PD-L1 in HIF-1 and PD-L1-related pathways. The gene discussed is HIF1A; the disease is non-small cell lung carcinoma.